This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Anti-snoring Devices and Snoring Surgery Market

Anti-snoring Devices and Snoring Surgery Market

Anti-snoring Devices and Snoring Surgery Market By Device (Mandibular Advancement, Tongue Stabilizing, Continuous Positive Airway Pressure (CPAP)), By Surgical Procedure (Uvulopalatopharyngoplasty, Tonsillectomy and Adenoidectomy) - Regional Forecast 2021-2031

Anti-snoring Devices and Snoring Surgery Market
  • Sep-2021
  • List of Tables : 73
  • List of Figures : 5
  • 170 Pages
  • Healthcare

Anti-snoring Devices and Snoring Surgery Market Outlook

The Global anti-snoring devices and snoring surgery industry was valued at around US$ 20 Bn in 2020. A five year compounded annual growth rate of 4% is projected until 2025, while long-term forecast projects the market to expand 2x to reach US$ 40 Bn by 2031. Patients showed high inclination towards uvulopalatopharyngoplasty (UPPP) surgeries, accounting for 41% revenue in 2020.

Key Points Addressed in Anti-Snoring Devices and Snoring Surgery Industry Analysis

  • Market Estimates and Forecasts (2016-2031)
  • Key Drivers and Restraints Shaping Market Growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand Share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Anti-Snoring Devices and Snoring Surgery and How to Navigate
  • Recommendation on Key Winning Strategies

Anti-Snoring Devices Revenue Analysis 2016-2020 vs Outlook for 2021-2031

According to Fact.MR’s report, anti-snoring devices and snoring surgery demand exhibited a CAGR of over 3% from 2016 to 2020. Sales have spiked in the wake of surging incidences of sleep apnea in the past few years. Sleep apnea occurs in about 25% of men and nearly 10% of women, and can affect people of all age groups.

This incidence is especially acute amongst obese people, particularly those aged above 50. Amidst the COVID-19 pandemic, anti-snoring devices experienced significant uptake, with studies concluding that patients with obstructive sleep apnea are vulnerable to adverse post-infection outcomes- such as obesity, hypertension and idiopathic pulmonary fibrosis.

Furthermore, as people increasingly lead sedentary lifestyles, sleep disorders are on the rise- leading to growing frequencies of sleep apnea amongst people. Based on these trends, the market for anti-snoring devices and snoring surgery will likely surge at a CAGR of 7.2% from 2021 to 2031.

How are Rising Obesity Cases Spurring Anti-Snoring Devices Demand?

Obesity has increased dramatically over the past 4 decades, with the United States ranking first in prevalence levels (36.5% from 2011-2014). This is followed by Europe, with an average prevalence rate of nearly 16%. This high prevalence rate is increasing episodes of sleep apnea across these regions.

The Netherlands, the United Kingdom, and Switzerland are the most likely to reach these maximum levels first. Obstructive sleep apnea is frequent amongst obese patients, with the National Sleep Foundation stating that 90 million adults were affected by snoring as of 2017. Hence, demand for anti-snoring devices is inclining significantly.

Avail customized purchase options for your needs

How is an Expanding Geriatrics Pool Stimulating Anti-Snoring Surgery Demand?

The market is expected to expand due to an increase in the geriatric population, as well as increased smoking and alcohol use, technical improvements in anti-snoring equipment, and more public awareness. Because the characteristics of weight increase are added in the elderly population.

According to the World Ageing Population study, there were roughly 702.9 million individuals aged 65 and over in 2019, with that figure predicted to rise to 1.5 billion by 2050. As a result of the aforementioned causes, the worldwide market for anti-snoring devices is expected to surge rapidly in forthcoming years.

Country-Wise Analysis

Why is the U.S a Highly Opportunistic Market for Anti-Snoring Devices?

The anti-snoring market is presently dominated by North America, with the U.S and Canada yielding substantial growth opportunities. As of 2019, the market in the U.S contributed US$ 8.3 Bn in revenue to the North American landscape.

According to the Sleep Foundation, around 57% of males and 40% females snored as of 2019. Furthermore according to the Centers for Disease Control and Prevention, the obesity prevalence in the United States was at 42.4% in 2019, up 26% since 2008.

Recently, in February 2021, the Food & Drug Administration authorized marketing of the eXciteOSA device to alleviate incidences of mild obstructive sleep apnea in patient ages 18 or above. Such initiatives are widening opportunities for anti-snoring devices sales in the country.

How Lucrative is the Market in the U.K?

According to data published by the National Health Service, between 2006 and 2019, 1.45 million diagnostic sleep tests were completed in England. 50% of these tests generated a continuous positive airway pressure (CPAP) therapy for apnea patients.

As per the study, currently approximately 700,000 people in the U.K successfully affiliated with CPAP therapy. Based on these promising figures, prominent anti-snoring device manufacturers have successfully established base in the U.K market. Fact.MR expects it to surge at around 7% CAGR through 2031.

Why China is a Prominent Market for Anti-Snoring Devices?

China's anti-snoring device industry accounts for a major portion of the Asian anti-snoring device industry's revenue. Due to factors such as an ever-increasing population with snoring problems, the presence of key market players in the region, and a large gap between the number of patients who have been treated and those who have yet to be treated, it is expected to grow substantially.

China's healthcare environment is improving at a rapid pace, with the market for anti-snoring gadgets and snoring surgery increasing at an exponential rate. Furthermore, the region is home to prominent e-Commerce businesses (such as Alibaba), indicating that anti-snoring devices have a strong online sales potential. Nearly 50% of Asian market revenue will be generated by China.

An Adaptive Approach to Modern-day Research Needs

Category-Wise Insights

Why are Continuous Positive Airway Pressure (CPAP) Devices Prominent?

The continuous positive airway pressure (CPAP) devices sub-segment is estimated to have the largest market size in the anti-snoring devices category. In the midst of this epidemic, demand for CPAP machines and masks is likely to grow, as CPAP equipment have been found to help manage COVID-19 symptoms including breathing difficulty.

In situations of airway obstructions, continuous positive airway pressure (CPAP) devices are utilized to force air into the clogged airways and open them up. According to Fact.MR, CPAP devices will likely account for 1/3rd of global revenue.

Why the Rising Preference for Uvulopalatopharyngoplasty (UPPP) Surgery?

According to Fact.MR’s data, preference for uvulopalatopharyngoplasty (UPPP) surgery captured 41% revenue share in 2020. UPPP can be performed by an ENT specialist to address large or elongated uvula, loud snoring and OSA.

Long-term relief from airway obstruction, higher oxygen intake levels during sleep, improved snoring and lowered blood pressure are some of the key benefits resulting from UPPP therapy.  

Competitive Landscape

The anti-snoring landscape is highly fragmented. Few large firms presently dominate the industry in terms of market share. Mid-size to smaller firms, on the other hand, are expanding their market presence by introducing new ingredients at lower prices, thanks to technical advancements and product innovation.

  • In June 2019, InnAccel launched SAANS, a CPAP solution. It is one of the first infrastructure-free, portable, and neonatal CPAP systems in the world, providing a continuous flow of air to prevent the airway from collapsing. It also removes the tissue vibrations that induce snoring.
  • In July 2020, Fisher & Paykel Healthcare inaugurated its 4th research and manufacturing facility at its Daniell Building in New Zealand. This expansion is expected to aid the company in continuing developing and delivering leading healthcare solutions associated with sleep disorders

Interested to Procure The Data

Report Scope



Market size value in 2020

USD 20 Billion

Market forecast value in 2031

USD 40 Billion

Growth Rate

CAGR of 7.2% from 2021 to 2031

Forecast Period


Historical Data Available for


Market Analysis

US$ Mn for Value & ‘000 Units for Volume

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania 
  • MEA

Key Countries Covered

  • U.S
  • Canada
  • Germany
  • U.K
  • France
  • Nordics
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Brazil
  • Mexico
  • GCC
  • South Africa

Key Market Segments Covered

  • Device
  • Surgical Procedure
  • Region

Key Companies Profiled

  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips NV
  • ResMed
  • ASF Medical GmbH (Tomed GmbH)
  • Apnea Sciences


Available upon Request

Key Segments Covered

  • Device

    • Mandibular Advancement Anti-Snoring Devices (MAD)
    • Tongue Stabilizing Anti-Snoring Device (TSD)
    • Continuous Positive Airway Pressure (CPAP) Anti-Snoring Devices
    • Others (Nasal and Chin Strips, Straps, Rings, etc.)
  • Surgical Procedure

    • Uvulopalatopharyngoplasty (UPPP) Snoring Surgery
    • Tonsillectomy and Adenoidectomy Snoring Surgery
    • Maxillo-Mandibular and Genloglossus Advancement Surgeries
    • Radiofrequency Ablation (RFA) Snoring Surgery
    • Pillar Procedure with Palatal Implants Snoring Surgery

- FAQs -

As of 2020, the global market for anti-snoring devices & snoring surgery reached US$ 20 Bn

From 2016 to 2020, anti-snoring devices sales expanded at a CAGR of 3%

By 2025, anti-snoring devices sales will likely surge at a CAGR of 4%

According to Fact.MR, anti-snoring devices and snoring surgery industry will likely expand at 7.2% CAGR to reach US$ 40 Bn

Increased prevalence of sleep apnea is spurring uptake of anti-snoring devices and surgeries

As of 2019, the anti-snoring devices and snoring surgery industry contributed US$ 8.3 Bn in 2019

Demand for anti-snoring devices and snoring surgeries is likely to expand at 7% CAGR until 2031

As per Fact.MR, almost 50% of the anti-snoring devices revenue will be generated by China

Uvulopalatopharyngoplasty (UPPP) surgery will reign supreme, capturing 41% of revenue in 2020

Continuous positive airway pressure (CPAP) devices are preferred, accounting for 1/3rd of global revenues until 2031

Need an Exclusive Report for your Unique Requirement?

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.